| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Regulation | 48 | 2026 | 2023 | 6.290 |
Why?
|
| Induced Pluripotent Stem Cells | 17 | 2026 | 147 | 5.560 |
Why?
|
| Quantitative Trait Loci | 35 | 2026 | 665 | 5.410 |
Why?
|
| Pan troglodytes | 18 | 2023 | 203 | 4.140 |
Why?
|
| Myocytes, Cardiac | 9 | 2022 | 328 | 3.230 |
Why?
|
| Sequence Analysis, RNA | 23 | 2026 | 272 | 3.140 |
Why?
|
| Genomics | 12 | 2026 | 903 | 2.960 |
Why?
|
| Primates | 11 | 2026 | 164 | 2.950 |
Why?
|
| Genetic Variation | 21 | 2021 | 1454 | 2.880 |
Why?
|
| Cell Differentiation | 13 | 2024 | 1647 | 2.730 |
Why?
|
| Gene Expression Profiling | 35 | 2023 | 1568 | 2.610 |
Why?
|
| DNA Methylation | 14 | 2020 | 735 | 2.450 |
Why?
|
| Gene Expression | 13 | 2020 | 1322 | 2.390 |
Why?
|
| Evolution, Molecular | 14 | 2020 | 904 | 2.050 |
Why?
|
| Cell Line | 30 | 2026 | 2483 | 1.860 |
Why?
|
| Gene Regulatory Networks | 7 | 2025 | 340 | 1.650 |
Why?
|
| Computational Biology | 8 | 2020 | 618 | 1.640 |
Why?
|
| Embryoid Bodies | 2 | 2023 | 2 | 1.520 |
Why?
|
| Single-Cell Analysis | 6 | 2024 | 226 | 1.510 |
Why?
|
| Species Specificity | 18 | 2026 | 690 | 1.480 |
Why?
|
| Chromatin | 11 | 2020 | 461 | 1.420 |
Why?
|
| Stress, Physiological | 3 | 2025 | 257 | 1.410 |
Why?
|
| Macaca mulatta | 6 | 2020 | 466 | 1.390 |
Why?
|
| Papio | 2 | 2026 | 91 | 1.380 |
Why?
|
| Epigenesis, Genetic | 10 | 2021 | 589 | 1.330 |
Why?
|
| Selection, Genetic | 6 | 2020 | 572 | 1.300 |
Why?
|
| RNA, Messenger | 13 | 2016 | 2070 | 1.260 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2026 | 2579 | 1.220 |
Why?
|
| Animals | 46 | 2026 | 28981 | 1.160 |
Why?
|
| Disease | 2 | 2026 | 92 | 1.150 |
Why?
|
| Genome, Human | 16 | 2022 | 834 | 1.100 |
Why?
|
| Oxygen | 2 | 2025 | 773 | 1.090 |
Why?
|
| Humans | 101 | 2026 | 98370 | 1.090 |
Why?
|
| Genome-Wide Association Study | 15 | 2026 | 1859 | 1.050 |
Why?
|
| Genome | 10 | 2026 | 417 | 1.030 |
Why?
|
| Polyadenylation | 3 | 2021 | 13 | 1.000 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2020 | 403 | 0.950 |
Why?
|
| Hypoxia | 2 | 2021 | 682 | 0.860 |
Why?
|
| Transcription Factors | 13 | 2016 | 1721 | 0.860 |
Why?
|
| Software | 4 | 2026 | 697 | 0.850 |
Why?
|
| Histones | 6 | 2014 | 364 | 0.850 |
Why?
|
| Organoids | 1 | 2025 | 92 | 0.840 |
Why?
|
| Chromatin Assembly and Disassembly | 4 | 2020 | 80 | 0.840 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2020 | 578 | 0.830 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 6 | 2020 | 171 | 0.820 |
Why?
|
| Protein Biosynthesis | 3 | 2016 | 393 | 0.790 |
Why?
|
| RNA Stability | 3 | 2014 | 98 | 0.770 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 198 | 0.750 |
Why?
|
| Models, Genetic | 6 | 2019 | 1006 | 0.750 |
Why?
|
| Metagenome | 2 | 2014 | 123 | 0.730 |
Why?
|
| Transcriptome | 8 | 2023 | 824 | 0.680 |
Why?
|
| Transcription, Genetic | 5 | 2014 | 1133 | 0.680 |
Why?
|
| Epigenomics | 4 | 2016 | 111 | 0.630 |
Why?
|
| Conserved Sequence | 1 | 2020 | 209 | 0.620 |
Why?
|
| Osteogenesis | 1 | 2022 | 279 | 0.620 |
Why?
|
| Protein Domains | 1 | 2020 | 170 | 0.610 |
Why?
|
| Receptors, Odorant | 3 | 2016 | 38 | 0.600 |
Why?
|
| Phenotype | 12 | 2024 | 2667 | 0.580 |
Why?
|
| Genetic Loci | 2 | 2017 | 263 | 0.580 |
Why?
|
| Disease Models, Animal | 1 | 2026 | 2577 | 0.580 |
Why?
|
| Phosphopeptides | 1 | 2018 | 11 | 0.560 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 9 | 0.560 |
Why?
|
| Research Design | 2 | 2020 | 651 | 0.550 |
Why?
|
| Cell Cycle | 1 | 2020 | 519 | 0.550 |
Why?
|
| Anthracyclines | 1 | 2018 | 31 | 0.540 |
Why?
|
| Cardiotoxicity | 1 | 2018 | 19 | 0.540 |
Why?
|
| Proteome | 2 | 2018 | 164 | 0.520 |
Why?
|
| Gene Silencing | 1 | 2018 | 178 | 0.520 |
Why?
|
| DNA Transposable Elements | 1 | 2018 | 170 | 0.510 |
Why?
|
| Phosphoproteins | 1 | 2018 | 264 | 0.510 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 396 | 0.510 |
Why?
|
| Liver | 5 | 2015 | 1230 | 0.500 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2014 | 48 | 0.490 |
Why?
|
| Smell | 2 | 2016 | 123 | 0.490 |
Why?
|
| Chromosome Mapping | 6 | 2026 | 1064 | 0.490 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2017 | 270 | 0.480 |
Why?
|
| Tuberculosis | 4 | 2017 | 126 | 0.480 |
Why?
|
| Cells, Cultured | 6 | 2024 | 2858 | 0.470 |
Why?
|
| Chlorambucil | 1 | 2015 | 13 | 0.470 |
Why?
|
| Carbamates | 1 | 2015 | 15 | 0.470 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2018 | 2574 | 0.460 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 43 | 0.460 |
Why?
|
| Myocardium | 1 | 2018 | 578 | 0.450 |
Why?
|
| Sequence Analysis, DNA | 7 | 2015 | 917 | 0.450 |
Why?
|
| Herpesvirus 4, Human | 3 | 2015 | 127 | 0.440 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2017 | 214 | 0.440 |
Why?
|
| Dendritic Cells | 3 | 2017 | 552 | 0.430 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 51 | 0.430 |
Why?
|
| Genotype | 8 | 2018 | 1892 | 0.430 |
Why?
|
| Camptothecin | 1 | 2015 | 198 | 0.430 |
Why?
|
| Brain | 1 | 2025 | 2439 | 0.420 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 202 | 0.410 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 102 | 0.400 |
Why?
|
| Metabolomics | 1 | 2014 | 108 | 0.400 |
Why?
|
| Olfactory Perception | 1 | 2014 | 25 | 0.400 |
Why?
|
| B-Lymphocytes | 3 | 2015 | 731 | 0.390 |
Why?
|
| RNA | 2 | 2020 | 596 | 0.390 |
Why?
|
| Genes, rRNA | 1 | 2013 | 7 | 0.380 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 327 | 0.380 |
Why?
|
| Alternative Splicing | 3 | 2021 | 226 | 0.380 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2013 | 17 | 0.370 |
Why?
|
| Microbial Consortia | 1 | 2013 | 17 | 0.370 |
Why?
|
| Physiology, Comparative | 1 | 2012 | 4 | 0.370 |
Why?
|
| Seasons | 1 | 2014 | 252 | 0.370 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 150 | 0.360 |
Why?
|
| Pluripotent Stem Cells | 2 | 2024 | 38 | 0.360 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 3 | 0.360 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2012 | 6 | 0.360 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 99 | 0.350 |
Why?
|
| Biological Evolution | 3 | 2020 | 1079 | 0.350 |
Why?
|
| Microbiota | 2 | 2017 | 472 | 0.350 |
Why?
|
| Social Environment | 1 | 2013 | 199 | 0.350 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 299 | 0.340 |
Why?
|
| Adaptation, Biological | 1 | 2012 | 89 | 0.340 |
Why?
|
| Immunity, Innate | 2 | 2015 | 482 | 0.330 |
Why?
|
| Cell Transformation, Viral | 1 | 2011 | 38 | 0.330 |
Why?
|
| Bacteria | 1 | 2015 | 546 | 0.330 |
Why?
|
| Genetic Speciation | 1 | 2012 | 127 | 0.330 |
Why?
|
| Principal Component Analysis | 4 | 2017 | 170 | 0.330 |
Why?
|
| Lymphocytes | 5 | 2021 | 461 | 0.310 |
Why?
|
| Asthma | 3 | 2016 | 1082 | 0.300 |
Why?
|
| DNA | 5 | 2014 | 1275 | 0.300 |
Why?
|
| Female | 20 | 2026 | 51761 | 0.300 |
Why?
|
| Social Behavior | 1 | 2012 | 316 | 0.290 |
Why?
|
| Behavior, Animal | 1 | 2012 | 399 | 0.280 |
Why?
|
| Exons | 5 | 2014 | 457 | 0.280 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 661 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 980 | 0.260 |
Why?
|
| Binding Sites | 4 | 2014 | 1160 | 0.260 |
Why?
|
| Feces | 3 | 2015 | 390 | 0.250 |
Why?
|
| Sex Characteristics | 1 | 2008 | 352 | 0.240 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 2896 | 0.230 |
Why?
|
| Gene-Environment Interaction | 2 | 2025 | 125 | 0.230 |
Why?
|
| Deoxyribonuclease I | 4 | 2012 | 27 | 0.230 |
Why?
|
| Sequence Alignment | 1 | 2026 | 353 | 0.220 |
Why?
|
| Ribosomes | 2 | 2016 | 106 | 0.220 |
Why?
|
| Thrombocytopenia | 1 | 2026 | 194 | 0.210 |
Why?
|
| Cell Line, Transformed | 3 | 2014 | 153 | 0.210 |
Why?
|
| Molecular Sequence Annotation | 3 | 2014 | 80 | 0.210 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2015 | 139 | 0.210 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 2381 | 0.210 |
Why?
|
| HapMap Project | 3 | 2014 | 47 | 0.210 |
Why?
|
| Male | 14 | 2022 | 47263 | 0.210 |
Why?
|
| Cell Culture Techniques | 2 | 2022 | 198 | 0.210 |
Why?
|
| Protein Binding | 4 | 2015 | 1561 | 0.190 |
Why?
|
| Biology | 1 | 2023 | 53 | 0.190 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 144 | 0.190 |
Why?
|
| Germ-Line Mutation | 1 | 2026 | 402 | 0.180 |
Why?
|
| Base Sequence | 6 | 2026 | 2224 | 0.180 |
Why?
|
| Alleles | 4 | 2015 | 1163 | 0.180 |
Why?
|
| Biodiversity | 2 | 2015 | 252 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 700 | 0.180 |
Why?
|
| Macrophages | 2 | 2015 | 643 | 0.170 |
Why?
|
| Bayes Theorem | 5 | 2018 | 420 | 0.170 |
Why?
|
| Aging | 1 | 2026 | 770 | 0.170 |
Why?
|
| Gene Dosage | 2 | 2012 | 216 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2016 | 3633 | 0.160 |
Why?
|
| Nigeria | 2 | 2019 | 174 | 0.160 |
Why?
|
| Mice | 9 | 2016 | 12735 | 0.150 |
Why?
|
| Genes, Reporter | 1 | 2020 | 277 | 0.150 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 169 | 0.150 |
Why?
|
| Olfactory Mucosa | 2 | 2016 | 33 | 0.140 |
Why?
|
| Cell Lineage | 2 | 2022 | 332 | 0.140 |
Why?
|
| Pregnancy | 1 | 2026 | 3269 | 0.140 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 2 | 2016 | 36 | 0.140 |
Why?
|
| Adult | 9 | 2018 | 29587 | 0.140 |
Why?
|
| Endoderm | 1 | 2018 | 25 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2020 | 615 | 0.140 |
Why?
|
| Open Reading Frames | 2 | 2016 | 118 | 0.140 |
Why?
|
| Datasets as Topic | 1 | 2018 | 85 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 108 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 307 | 0.130 |
Why?
|
| Latent Tuberculosis | 1 | 2017 | 20 | 0.130 |
Why?
|
| Doxorubicin | 1 | 2018 | 285 | 0.130 |
Why?
|
| Actinobacteria | 1 | 2017 | 11 | 0.130 |
Why?
|
| Nasopharynx | 1 | 2017 | 51 | 0.120 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 71 | 0.120 |
Why?
|
| Transcription Initiation Site | 3 | 2012 | 49 | 0.120 |
Why?
|
| Pseudogenes | 2 | 2016 | 39 | 0.120 |
Why?
|
| Lipocalins | 1 | 2016 | 34 | 0.120 |
Why?
|
| Nose | 1 | 2017 | 97 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 250 | 0.120 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 114 | 0.120 |
Why?
|
| Proteomics | 1 | 2018 | 280 | 0.120 |
Why?
|
| Immune System Diseases | 1 | 2016 | 25 | 0.120 |
Why?
|
| Phospholipase D | 1 | 2015 | 13 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2016 | 153 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2018 | 1145 | 0.120 |
Why?
|
| Molecular Biology | 1 | 2016 | 83 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 86 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 822 | 0.110 |
Why?
|
| Response Elements | 1 | 2015 | 68 | 0.110 |
Why?
|
| Common Cold | 1 | 2015 | 14 | 0.110 |
Why?
|
| RNA, Untranslated | 2 | 2012 | 70 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2015 | 77 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 79 | 0.110 |
Why?
|
| 3' Flanking Region | 1 | 2014 | 5 | 0.110 |
Why?
|
| Phylogeny | 4 | 2016 | 1340 | 0.110 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 16 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2015 | 304 | 0.110 |
Why?
|
| Sequence Analysis | 2 | 2012 | 25 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 427 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 670 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 211 | 0.110 |
Why?
|
| Freezing | 1 | 2014 | 30 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2019 | 1147 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 1094 | 0.110 |
Why?
|
| RNA Splicing | 1 | 2016 | 163 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 130 | 0.100 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 2 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2015 | 184 | 0.100 |
Why?
|
| Cooking | 1 | 2014 | 71 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 302 | 0.100 |
Why?
|
| Databases, Genetic | 2 | 2012 | 289 | 0.100 |
Why?
|
| Genes | 1 | 2014 | 256 | 0.100 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 63 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 316 | 0.100 |
Why?
|
| Mitochondria | 1 | 2017 | 650 | 0.090 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 4 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2016 | 766 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2016 | 710 | 0.090 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 28 | 0.090 |
Why?
|
| Nucleosomes | 1 | 2012 | 63 | 0.090 |
Why?
|
| DNA Footprinting | 1 | 2012 | 16 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2792 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 218 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 553 | 0.090 |
Why?
|
| Models, Animal | 1 | 2013 | 282 | 0.090 |
Why?
|
| Darkness | 1 | 2011 | 47 | 0.090 |
Why?
|
| Lemur | 1 | 2011 | 16 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 61 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1947 | 0.090 |
Why?
|
| Omentum | 1 | 2012 | 69 | 0.090 |
Why?
|
| Genetic Complementation Test | 2 | 2008 | 85 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2015 | 867 | 0.090 |
Why?
|
| RNA Interference | 1 | 2012 | 388 | 0.090 |
Why?
|
| Diet | 1 | 2014 | 469 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1397 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 621 | 0.080 |
Why?
|
| Linear Models | 1 | 2012 | 426 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2013 | 449 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 311 | 0.080 |
Why?
|
| Viral Load | 1 | 2011 | 162 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 106 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2013 | 384 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1791 | 0.070 |
Why?
|
| Monocytes | 1 | 2010 | 220 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 1268 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 313 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 1974 | 0.070 |
Why?
|
| Testis | 1 | 2009 | 149 | 0.070 |
Why?
|
| Middle Aged | 6 | 2017 | 29532 | 0.070 |
Why?
|
| Obesity | 1 | 2015 | 1077 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2012 | 608 | 0.060 |
Why?
|
| Lung | 2 | 2016 | 1408 | 0.060 |
Why?
|
| Algorithms | 1 | 2015 | 2003 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2008 | 261 | 0.060 |
Why?
|
| Sex Factors | 1 | 2009 | 1142 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 2016 | 87 | 0.060 |
Why?
|
| Young Adult | 3 | 2017 | 7568 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 828 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2026 | 197 | 0.050 |
Why?
|
| Kidney | 1 | 2009 | 1121 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2016 | 830 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1775 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 3285 | 0.050 |
Why?
|
| Benchmarking | 1 | 2021 | 86 | 0.040 |
Why?
|
| Terminator Regions, Genetic | 2 | 2012 | 12 | 0.040 |
Why?
|
| RNA Splice Sites | 2 | 2010 | 60 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 2897 | 0.040 |
Why?
|
| Primitive Streak | 1 | 2018 | 2 | 0.040 |
Why?
|
| Introns | 2 | 2010 | 302 | 0.040 |
Why?
|
| France | 1 | 2017 | 53 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2016 | 25 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 5577 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2016 | 114 | 0.030 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2015 | 6 | 0.030 |
Why?
|
| Mycobacterium smegmatis | 1 | 2015 | 7 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2016 | 39 | 0.030 |
Why?
|
| Staphylococcus epidermidis | 1 | 2015 | 16 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 38 | 0.030 |
Why?
|
| Mycobacterium bovis | 1 | 2015 | 16 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 33 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 2015 | 6 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 22 | 0.030 |
Why?
|
| HMGA2 Protein | 1 | 2015 | 15 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 375 | 0.030 |
Why?
|
| Integrin alpha2 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2015 | 5 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 190 | 0.030 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2015 | 9 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 145 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 304 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2015 | 7 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 169 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 121 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 177 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2015 | 258 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2015 | 116 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 2014 | 38 | 0.030 |
Why?
|
| Triazoles | 1 | 2015 | 118 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 124 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 256 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 76 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 96 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 392 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2015 | 134 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2014 | 74 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 213 | 0.030 |
Why?
|
| CCCTC-Binding Factor | 1 | 2013 | 20 | 0.030 |
Why?
|
| Artifacts | 1 | 2015 | 248 | 0.030 |
Why?
|
| Cells | 1 | 2013 | 30 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2017 | 670 | 0.020 |
Why?
|
| Haplotypes | 1 | 2015 | 657 | 0.020 |
Why?
|
| Micrococcal Nuclease | 1 | 2012 | 8 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1110 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 1195 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 442 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2012 | 35 | 0.020 |
Why?
|
| Olfactory Bulb | 1 | 2012 | 41 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2050 | 0.020 |
Why?
|
| Statistical Distributions | 1 | 2012 | 9 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 41 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 2009 | 0.020 |
Why?
|
| Endangered Species | 1 | 2011 | 27 | 0.020 |
Why?
|
| Madagascar | 1 | 2011 | 40 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 291 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 137 | 0.020 |
Why?
|
| Nucleotides | 1 | 2011 | 93 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 206 | 0.020 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2010 | 5 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2010 | 7 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 249 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 804 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 301 | 0.020 |
Why?
|
| Dogs | 1 | 2011 | 642 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 779 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 1028 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2010 | 63 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 889 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 832 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 359 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 380 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 4126 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3616 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 10140 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 21844 | 0.010 |
Why?
|